Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn H Jones

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Organic Letters|April 7, 2006
A concise and selective synthesis of novel 5-aryloxyimidazole NNRTIsLyn H Jones, Thomas Dupont, Charles E Mowbray, et al.
British Journal of Pharmacology|November 13, 2025
Ligandability assessment of interferonopathy-associated proteins using chemoproteomicsNathan M Alba, Carys R Jones, Ffion L Jones, et al.
Nature Chemical Biology|May 17, 2015
Know your target, know your moleculeMark E Bunnage, Adam M Gilbert, Lyn H Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2007
Design and synthesis of a fluorescent muscarinic antagonistLyn H Jones, Amy Randall, Carolyn Napier, et al.
Medchemcomm|August 16, 2018
Quantitative measurement of intracellular HDAC1/2 drug occupancy using a <i>trans</i>-cyclooctene largazole thiol probeHua Xu, Lee R Roberts, Song Chou, et al.
Journal of the American Chemical Society|October 11, 2008
Helix persistence and breakdown in oligoureas of metaphenylenediamine: apparent diastereotopicity as a spectroscopic marker of helix length in solutionJonathan Clayden, Loïc Lemiègre, Gareth A Morris, et al.
Chemical Science|January 26, 2024
The Minimum Protein Staple? - Towards 'bio'-Baldwin's rules <i>via</i> inter-phosphosite linking in the MEK1 activation loopSébastien R G Galan, Ritu Raj, Dimitrios Mamalis, et al.
Journal of Medicinal Chemistry|August 26, 2011
Efficient conversion of a nonselective norepinephrin reuptake inhibitor into a dual muscarinic antagonist-β₂-agonist for the treatment of chronic obstructive pulmonary diseaseRachel Osborne, Nick Clarke, Paul Glossop, et al.
Chemistry & Biology|February 27, 2013
Developing irreversible inhibitors of the protein kinase cysteinomeQingsong Liu, Yogesh Sabnis, Zheng Zhao, et al.
Organic & Biomolecular Chemistry|June 11, 2016
Modern advances in heterocyclic chemistry in drug discoveryAlexandria P Taylor, Ralph P Robinson, Yvette M Fobian, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Organic Letters|April 7, 2006
A concise and selective synthesis of novel 5-aryloxyimidazole NNRTIsLyn H Jones, Thomas Dupont, Charles E Mowbray, et al.
British Journal of Pharmacology|November 13, 2025
Ligandability assessment of interferonopathy-associated proteins using chemoproteomicsNathan M Alba, Carys R Jones, Ffion L Jones, et al.
Nature Chemical Biology|May 17, 2015
Know your target, know your moleculeMark E Bunnage, Adam M Gilbert, Lyn H Jones, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2007
Design and synthesis of a fluorescent muscarinic antagonistLyn H Jones, Amy Randall, Carolyn Napier, et al.
Medchemcomm|August 16, 2018
Quantitative measurement of intracellular HDAC1/2 drug occupancy using a <i>trans</i>-cyclooctene largazole thiol probeHua Xu, Lee R Roberts, Song Chou, et al.
Journal of the American Chemical Society|October 11, 2008
Helix persistence and breakdown in oligoureas of metaphenylenediamine: apparent diastereotopicity as a spectroscopic marker of helix length in solutionJonathan Clayden, Loïc Lemiègre, Gareth A Morris, et al.
Chemical Science|January 26, 2024
The Minimum Protein Staple? - Towards 'bio'-Baldwin's rules <i>via</i> inter-phosphosite linking in the MEK1 activation loopSébastien R G Galan, Ritu Raj, Dimitrios Mamalis, et al.
Journal of Medicinal Chemistry|August 26, 2011
Efficient conversion of a nonselective norepinephrin reuptake inhibitor into a dual muscarinic antagonist-β₂-agonist for the treatment of chronic obstructive pulmonary diseaseRachel Osborne, Nick Clarke, Paul Glossop, et al.
Chemistry & Biology|February 27, 2013
Developing irreversible inhibitors of the protein kinase cysteinomeQingsong Liu, Yogesh Sabnis, Zheng Zhao, et al.
Organic & Biomolecular Chemistry|June 11, 2016
Modern advances in heterocyclic chemistry in drug discoveryAlexandria P Taylor, Ralph P Robinson, Yvette M Fobian, et al.
Pageof 12